Transcriptome + genome |
DR-seq |
gDNA |
mRNA |
- |
- |
13 cells |
No |
No |
CNVs; gene expression |
2015 |
Nat Biotechnol |
Dey et al. |
G&T-seq |
gDNA |
Full-length mRNA |
- |
- |
~200 cells |
Yes; oligo-dT-coated magnetic beads |
No |
Chromosomal aneuploidies; inter-chromosomal fusions; SNVs; chromosomal rearrangements; gene expression |
2015 |
Nat Methods |
Macaulay et al. |
SIDR-seq |
gDNA |
Total RNA (including non-coding RNA) |
- |
- |
43 cells |
Yes; hypotonic lysis and antibody-conjugated magnetic microbeads |
No |
Genomic variations; transcriptomic patterns |
2018 |
Genome Res |
Han et al. |
TARGET-seq |
Target gDNA |
mRNA; target mRNA |
- |
- |
4559 cells |
No |
Yes |
Known target somatic mutations; SNVs,small indels; gene expression |
2019 |
Mol Cell |
Rodriguez-Meira et al. |
Transcriptome + genome +methylome |
scTrio-seq |
gDNA |
Cytosolic mRNA |
gDNA methylation |
- |
25 cells |
Yes; centrifugation |
No |
CNVs; promoter and gene body methylation levels; gene expression |
2016 |
Cell Res |
Hou et al. |
Transcriptome + methylome |
scM&T-seq |
- |
Full-length mRNA |
gDNA methylation |
- |
61 cells |
Yes; oligo-dT-coated magnetic beads |
Yes |
DNA methylome data; transcriptome data |
2016 |
Nat Methods |
Angermueller et al. |
scMT-seq |
- |
Cytosolic mRNA |
gDNA methylation |
- |
9 cells |
Yes; micropipette |
No |
Methylome, SNPs and transcriptome data |
2016 |
Genome Biol |
Hu et al. |
Transcriptome + chromatin accessibility |
sci-CAR |
- |
Nuclear mRNA |
chromatin accessibility |
- |
~10,000 nuclei |
No |
Yes |
Chromatin accessibility and gene expression |
2018 |
Science |
Cao et al. |
scCAT-seq |
- |
Cytosolic mRNA |
Chromatin accessibility |
- |
176 cells |
Yes; mild lysis and physical dissociation |
Yes |
2019 |
Nat Commun |
Liu et al. |
SNARE-seq |
- |
Nuclear mRNA |
Chromatin accessibility |
- |
~10,000 nuclei |
No |
Yes |
2019 |
Nat Biotechnol |
Chen et al. |
SNARE-seq2 |
- |
mRNA |
Chromatin accessibility |
- |
>80,000 nuclei or cells |
No |
Yes |
2021 |
Nat Protocols |
Plongthongkum et al. |
Paired-seq |
- |
Nuclear mRNA |
Chromatin accessibility |
- |
>10,000 nuclei |
No |
Yes |
2019 |
Nat Struct Mol Biol |
Zhu et al. |
SHARE-seq |
- |
mRNA |
Chromatin accessibility |
- |
>10,000 cells or nuclei |
No |
Yes |
2020 |
Cell |
Ma et al. |
ISSAAC-seq |
- |
Nuclear mRNA |
Chromatin accessibility |
- |
>10,000 nuclei |
No |
Yes |
2022 |
Nat Methods |
Xu et al. |
Transcriptome + histone modification |
EpiDamID |
- |
Total mRNA |
Histone modification |
- |
2,943 cells |
No |
No |
Histone modification and gene expression |
2022 |
Mol Cell |
Rang et al. |
Genome + methylome |
Methyl-HiC |
gDNA |
- |
gDNA methylation |
- |
150 nuclei |
No |
No |
General features of chromosomal architecture (chromatin loops, TADs); DNA methylome |
2019 |
Nat Methods |
Li et al. |
sn-m3C-seq |
gDNA |
- |
gDNA methylation |
- |
~4200 nuclei |
No |
No |
3D chromatin conformation; Cytosine DNA methylation |
2019 |
Nat Methods |
Lee et al. |
Single-cell COOL-seq |
gDNA |
- |
gDNA methylation |
- |
24 nuclei |
No |
No |
Chromatin state; nucleosome position; DNA methylation; CNVs and ploidy |
2017 |
Cell Res |
Guo et al. |
Transcriptome + methylome + chromatin accessibility |
scNMT-seq |
- |
Cytosolic mRNA |
gDNA methylation; chromatin accessibility |
- |
70 cells |
Yes; oligo-dT-coated magnetic beads |
No |
Chromatin accessibility, DNA methylation; transcriptome |
2018 |
Nat Commun |
Clark et al. |
scNOMeRe-seq |
- |
Cytosolic mRNA |
gDNA methylation; chromatin accessibility |
- |
233 cells |
Yes; oligo-dT-coated magnetic beads |
No |
Single-cell nucleosome occupancy; DNA methylome; RNA expression |
2021 |
Nat Commun |
Wang et al. |
scChaRM-seq |
- |
mRNA |
gDNA methylation; chromatin accessibility |
- |
148 cells |
Yes; oligo-dT-coated magnetic beads |
No |
DNA methylome, chromatin accessibility and transcriptome |
2021 |
Cell Stem Cell |
Yan et al. |
Transcriptome + proteome |
PEA/STA |
- |
Target mRNA |
- |
38 surface proteins |
87 cells |
No |
No |
Gene and protein expression |
2016 |
Genome Biol |
Genshaft et al. |
PLAYR |
- |
40 target mRNA |
- |
40 surface proteins |
10,000 cells |
No |
Yes |
Protein epitopes and multiple RNA |
2016 |
Nat Methods |
Frei et al. |
CITE-seq |
- |
mRNA |
- |
>100 surface proteins |
8,005 cells |
No |
Yes |
Protein epitopes and transcriptomes |
2017 |
Nat Methods |
Stoeckius et al. |
REAP-seq |
- |
mRNA |
- |
82 surface proteins |
7,271 cells |
No |
Yes |
Protein epitopes and transcriptomes |
2017 |
Nat Biotechnol |
Peterson et al. |
ECCITE-seq |
- |
mRNA, V(D)J regions,perturbation gsRNA |
- |
>100 surface proteins |
5935 cells |
No |
Yes |
Proteome, V(D)J regions, transcriptome, clonotype and CRISPR perturbation information |
2019 |
Nat Methods |
Mimitou et al. |
Perturb-CITE-seq |
- |
mRNA,perturbation gsRNA |
- |
20 surface proteins |
~218,000 cells |
No |
Yes |
Proteome, transcriptome and CRISPR perturbation information |
2021 |
Nat Genet |
Frangieh et al. |
RAID |
- |
mRNA |
- |
6 intracellular (phospho-) proteins |
384 fixed cells |
No |
No |
Gene and protein expression |
2019 |
Sci Rep |
Gerlach et al. |
QuRIE-seq |
- |
mRNA |
- |
80 intra- or extracellular (phospho)proteins |
4,754 cells |
No |
Yes |
Gene and protein expression |
2021 |
Cell Rep Methods |
Rivello et al. |
INs-seq |
- |
mRNA |
- |
Several intracellular proteins |
5000 cells |
No |
Yes |
Single-cell transcriptional, signaling, TF, and metabolism maps |
2020 |
Cell |
Katzenelenbogen et al. |
inCITE-seq |
- |
Nuclear mRNA |
- |
Several intra-nuclear protein |
~10,000 nuclei |
No |
Yes |
Transcription factors (TFs) and gene expression |
2021 |
Nat Methods |
Chung et al. |
Epigenome + proteome |
ICICLE-seq |
- |
- |
Chromatin accessibility |
46 surface proteins |
>10,000 cells |
No |
Yes |
Chromatin accessibility; protein levels |
2021 |
Elife |
Swanson et al. |
Transcriptome + epigenome + proteome |
TEA-seq |
- |
mRNA |
Chromatin accessibility |
46 surface proteins |
>10,000 cells |
No |
Yes |
Chromatin accessibility; protein levels; gene expression |
2021 |
Elife |
Swanson et al. |
NEAT-seq |
- |
mRNA |
Chromatin accessibility |
Several intra-nuclear protein |
6000 cells |
No |
Yes |
TF gene locus chromatin accessibility, RNA expression, protein abundance and genome-wide TF binding motif accessibility |
2022 |
Nat Methods |
Chen et al. |
Genome + proteome |
Tapestri |
gDNA |
- |
- |
45 surface proteins |
~10,000 cells |
No |
Yes |
SNV, CNV and protein levels |
2022 |
Methods Mol Biol |
Ruff et al. |
Genome + epigenome + proteome |
PHAGE-ATAC |
mtDNA |
|
Chromatin accessibility |
Several intra- or extracellular proteins |
8366 cells |
No |
Yes |
Surface and intracellular proteins, chromatin accessibility and mtDNA |
2021 |
Nat Biotechnol |
Fiskin et al. |
ASAP-seq |
mtDNA |
- |
Chromatin accessibility |
>200 intra- or extracellular proteins |
>10,000 cells |
No |
Yes |
Chromatin accessibility; protein expression; somatic mtDNA mutations |
2021 |
Nat Biotechnol |
Mimitou et al. |
Transcriptome + genome + epigenome + proteome |
DOGMA-seq |
mtDNA |
mRNA |
Chromatin accessibility |
>200 intra- or extracellular proteins |
>10,000 cells |
No |
Yes |
Chromatin accessibility; gene and protein expression; somatic mtDNA mutations |
2021 |
Nat Biotechnol |
Mimitou et al. |
Spatial transcriptome + proteome |
DBiT-Seq |
- |
Spatial mRNA - 10μm |
- |
22 surface proteins |
Pre-fixed tissue section |
No |
Yes |
Spatial transcriptomics and proteins |
2020 |
Cell |
Liu et al. |
SM-Omics |
- |
Spatial mRNA - 100μm |
- |
multiplex proteins |
Pre-fixed tissue section |
No |
Yes |
2022 |
Nat Commun |
Vickovic et al. |
CosMx SMI |
- |
Spatial mRNA - 10μm |
- |
64 surface proteins |
Pre-fixed tissue section |
No |
No |
2022 |
Blood |
Gui et al. |
spatial CITE-seq |
- |
Spatial mRNA - 50μm |
- |
189 surface proteins |
Pre-fixed tissue section |
No |
Yes |
2022 |
Preprint |
Liu et al. |